Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

GM&C Life Sciences Fund

Investor type Venture Capital


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 31
Average round size
The average size of a deal this fund participated in
Portfolio companies 29
Rounds per year 5.17
Lead investments 15
Follow on index
How often the fund supports its portfolio startups at next rounds
Key employees Soon
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Medical Device

In 2015 was created GM&C Life Sciences Fund, which is appeared as VC. The fund was located in Europe if to be more exact in United Kingdom. The main office of represented VC is situated in the Alderley Edge.

Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. Among the various public portfolio startups of the fund, we may underline AMR Centre, SurgaColl, Proveca The fund has no exact preference in a number of founders of portfolio startups. We can highlight the next thriving fund investment areas, such as Medical, Therapeutics.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the GM&C Life Sciences Fund, startups are often financed by Wren Capital, The North West Fund, SBRI Healthcare. The meaningful sponsors for the fund in investment in the same round are UK Innovation & Science Seed Fund, Deepbridge Capital, Catapult Ventures. In the next rounds fund is usually obtained by EASME - EU Executive Agency for SMEs, 24 Haymarket, SciTech.

The top activity for fund was in 2016. Speaking about the real fund results, this VC is 53 percentage points more often commits exit comparing to other organizations. The fund is constantly included in 7-12 deals per year. The common things for fund are deals in the range of 1 - 5 millions dollars.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of GM&C Life Sciences Fund:
Typical Co-investors
GM&C Life Sciences Fund is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after GM&C Life Sciences Fund:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United Kingdom
Funds with similar focus located in United Kingdom:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
20|20 Fund -
ActnerLab Seoul, Seoul-t'ukpyolsi, South Korea
Atlas Holdings Connecticut, Greenwich, United States
CastleOak Securities -
Chertoff Group District of Columbia, United States, Washington
efu Investment Auckland, Auckland, New Zealand
Enerfo Central, Central Region, Singapore
ESADE Business School Barcelona, Catalonia, Spain
Founders Circle Capital California, San Francisco, United States
Jobs 4 NSW Australia, New South Wales, Sydney
Pont Mestres & Asociados -
RR Donnelley & Sons Chicago, Illinois, United States
Shearwater Capital Australia, Edgecliff, New South Wales
Shenzhen Fastprint Circuit Tech China, Guangdong, Tianjin
Silicon Laboratories Austin, Texas, United States
Silver Point Ventures Leiden, The Netherlands, Zuid-Holland
Soaring Startup Circle Venture Partners Boston, Massachusetts, United States
Techstars Atlanta in Partnership with Cox Enterprises Atlanta, Georgia, United States
Three Commas Beijing, Beijing, China
William Blair Circle -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

QV Bioelectronics

Advanced Materials
Health Care
Life Science
Medical Device
$1M30 Jun 2021 Manchester, England, United Kingdom


Health Care
24 Nov 2020 Manchester, England, United Kingdom

Panthera Biopartners

Clinical Trials
23 Sep 2020 United Kingdom, England


15 Jul 2020 Cheshire, England, United Kingdom

Pencil Biosciences

Health Care
$685K12 Dec 2019 United Kingdom, England

AMR Centre

$3M25 Mar 2019 United Kingdom, England


Health Care
Medical Device
05 Oct 2018 Manchester, England, United Kingdom


Big Data
Health Care
Life Science
$959K18 Sep 2018 United Kingdom, England

Nexus Labs (Surgical Teaching)

02 Aug 2018 United Kingdom, England


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent GM&C Life Sciences Fund?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: